David O Irabor1, Olayiwola A Oluwasola2, Olufemi J Ogunbiyi2, Olabiyi G Ogun2, Clement A Okolo2, Marilena Melas3, Stephen B Gruber3,4, Chanjuan Shi5, Leon Raskin6. 1. Department of Surgery, College of Medicine, University of Ibadan, Ibadan, Nigeria. 2. Department of Pathology, College of Medicine, University of Ibadan, Ibadan, Nigeria. 3. USC Norris Comprehensive Cancer Center, Los Angeles, CA, U.S.A. 4. Department of Preventive Medicine, University of Southern California, Los Angeles, CA, U.S.A. 5. Department of Pathology, Microbiology and Immunology, School of Medicine, Vanderbilt University Medical Center and Vanderbilt Ingram Comprehensive Cancer Center, Nashville, TN, U.S.A. 6. Division of Epidemiology, School of Medicine, Vanderbilt University Medical Center and Vanderbilt Ingram Comprehensive Cancer Center, Nashville, TN, U.S.A. leon.raskin@gmail.com.
Abstract
BACKGROUND: Colorectal cancer (CRC) is the fifth most common cancer in Africa, with significant differences in incidence, biology and clinical behavior from other populations. MATERIALS AND METHODS: We studied prevalence and clinicopathological features of microsatellite instability (MSI) and young onset CRC in 83 archival samples from the University of Ibadan, Nigeria. RESULTS: Nigerian cases of CRC were MSI-high in 43% and MSI-high CRC had significantly lower histological heterogeneity than microsatellite-stable CRC (20% vs. 55% respectively, p=0.046). Presence of signet ring cell differentiation (10-50% of tumor) was significantly higher in younger patients with CRC (<50 years) (odds ratio(OR)=5.93, 95% confidence interval(CI)=1.17-29.95, p=0.038). Poor differentiation (34%), invasive growth (96%), and high prevalence of mucinous (10%) and signet ring cell adenocarcinomas (4%) were among distinct features of Nigerian patients with CRC. CONCLUSION: MSI-high CRC is more common in West Africa and more detailed molecular and genetic analysis is warranted as CRC incidence and mortality continue to increase in the Sub-Saharan Africa. Copyright
BACKGROUND:Colorectal cancer (CRC) is the fifth most common cancer in Africa, with significant differences in incidence, biology and clinical behavior from other populations. MATERIALS AND METHODS: We studied prevalence and clinicopathological features of microsatellite instability (MSI) and young onset CRC in 83 archival samples from the University of Ibadan, Nigeria. RESULTS: Nigerian cases of CRC were MSI-high in 43% and MSI-high CRC had significantly lower histological heterogeneity than microsatellite-stable CRC (20% vs. 55% respectively, p=0.046). Presence of signet ring cell differentiation (10-50% of tumor) was significantly higher in younger patients with CRC (<50 years) (odds ratio(OR)=5.93, 95% confidence interval(CI)=1.17-29.95, p=0.038). Poor differentiation (34%), invasive growth (96%), and high prevalence of mucinous (10%) and signet ring cell adenocarcinomas (4%) were among distinct features of Nigerian patients with CRC. CONCLUSION: MSI-high CRC is more common in West Africa and more detailed molecular and genetic analysis is warranted as CRC incidence and mortality continue to increase in the Sub-Saharan Africa. Copyright
Authors: Avinash Sharma; Olusegun I Alatise; Adewale O Adisa; Olukayode A Arowolo; Olalekan Olasehinde; Olusola C Famurewa; Adeleye D Omisore; A O Komolafe; O Olaofe; Aba I Katung; Ayoola D Ibikunle; Ayoola A Egberongbe; Samuel A Olatoke; S O Agodirin; A O Adesiyun; Ademola Adeyeye; K Ibrahim; O A Kolawole; O L Idris; M O Adejumobi; Adebowale I Ajayi; Akinwumi O Olakanmi; Jeremy C Constable; Ken Seier; Mithat Gonen; Murray F Brennan; T Peter Kingham Journal: J Surg Oncol Date: 2019-11-19 Impact factor: 3.454
Authors: Olusegun I Alatise; Gregory C Knapp; Brendan Bebington; Patrick Ayodeji; Anna Dare; Jeremy Constable; Olalekan Olasehinde; T Peter Kingham Journal: World J Surg Date: 2021-09-05 Impact factor: 3.352
Authors: Olusegun I Alatise; Anna J Dare; Patrick A Akinyemi; Fatimah B Abdulkareem; Samuel A Olatoke; Gregory C Knapp; T Peter Kingham Journal: Lancet Glob Health Date: 2022-07 Impact factor: 38.927
Authors: Inas Elsayed; Robert Geraghty; Salwa O Mekki; Ahmed A Mohamedani; Susan Ahern; Omer E H Salim; Balgis B M Khalil; Sawsan Abdelrahim; Suliman H Suliman; Moawia M A Elhassan; Salah O Salah; Mohamed E Salih; Abubakr H Widatalla; Osman S Abdelhamed; Xiaosheng Wang; Éanna J Ryan; Des Winter; Salih Bakhiet; Kieran Sheahan Journal: Sci Rep Date: 2022-06-29 Impact factor: 4.996
Authors: George Kunnackal John; Vipin Das Villgran; Christine Caufield-Noll; Francis M Giardiello Journal: Fam Cancer Date: 2021-01-11 Impact factor: 2.375
Authors: Gregory C Knapp; Olusegun I Alatise; Olalekan O Olasehinde; Ademola Adeyeye; Omobolaji O Ayandipo; Martin R Weiser; T Peter Kingham Journal: J Glob Oncol Date: 2019-06
Authors: Gregory C Knapp; Olusegun Alatise; Bolatito Olopade; Marguerite Samson; Olalekan Olasehinde; Funmilola Wuraola; Oluwole O Odujoko; Akinwunmi O Komolafe; Olujide O Arije; Philip E Castle; J Joshua Smith; Martin R Weiser; T Peter Kingham Journal: PLoS One Date: 2021-01-12 Impact factor: 3.240
Authors: George Kunnackal John; Vipin Das Villgran; Christine Caufield-Noll; Francis Giardiello Journal: Fam Cancer Date: 2020-09-11 Impact factor: 2.375